🚀 Executive Mastery in Pharma Product Management – Lead Strategy. Command Growth.
Master Product Launch Strategy, Input Designing, Brand Lifecycle, Valuation, ai skill training & Omnichannel Leadership.
🚀 Executive Mastery in Pharma Product Management – Lead Strategy. Command Growth.
Master Product Launch Strategy, Input Designing, Brand Lifecycle, Valuation, ai skill training & Omnichannel Leadership.
Leaving content generation in healthcare to AI can be detrimental! #HealthcareCommunications #MedicalWriting #PharmaMarketing #AIinHealthcare #HumanExpertise #RegulatoryWriting #MedicalAffairs #ContentStrategy #Leadership
Von A wie "Advisory Bord" bis W wie "Wertschöpfung".
Das Wörterbuch der ärztlichen UnAbhängigkeit von Prof. Dr. med. Thomas Lempert gibt Einblicke in die Marketing-basierte Medizin und Ausblicke auf die ärztliche Freiheit.
👉https://mezis.de/category/woerterbuch
#ÄrztlicheFreiheit #Wörterbuch #Medizin #Pharmamarketing #bigpharma
Unlock expertise in #marketaccess #strategicmanagement #marketapprovals, and hashtag#compliance across global markets. The #ExecutiveProgram is designed for middle and top management professionals. Take demo today. #royedtraining
🚀 The Ultimate Pharma Business & Market Strategy Program! 🌍
#PharmaLeadership MarketAccess #HEOR #RegulatoryAffairs #PharmaStrategy #BusinessDevelopment #Forecasting #PharmaMarketing #RoyedTraining
Shionogi brings generative AI to medical conferences
#pharma #pharmaindustry #pharmamarketing #Shionogi #medicalconferences #AI #genAI
Shionogi is bringing AI warriors to life at medical conferences. With the help of ad agency FCBCURE, the biopharma added generative artificial intelligence to its already-running infectious disease “Warriors” campaign to create personalized images for people at medical conferences. Medical professionals can step into the photo booth — first unveiled
FDA finally finalises DTC ad rule, creating new standards for TV and radio
The FDA is finally final | The FDA is finally finalizing its rule on the need for direct-to-consumer (DTC) ads to present side effects and contraindications “in a clear, conspicuous and neutral manner” more than 10 years after closing the third and final comment period.
Boehringer Ingelheim debuts evolved company brand
https://www.mmm-online.com/home/channel/first-look-boehringer-ingelheim-debuts-evolved-company-brand
#pharma #pharmaceutical #PharmaceuticalIndustry #PharmaceuticalCompanies #pharmamarketing #BoehringerIngelhiem #Boehringer